The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

The first clinical experience with the new GORE® septal occluder (GSO)

EuroIntervention 2013;9:959-963 published online ahead of print June 2013. DOI: 10.4244/EIJV9I8A160

Lars Søndergaard
Lars Søndergaard1*, MD; Poay Huan Loh1,2, MD; Olaf Franzen1, MD; Nikolaj Ihlemann1, MD; Niels Vejlstrup1, MD
1. The Heart Center, Rigshospitalet University Hospital, Copenhagen, Denmark; 2. Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

Aims: A new GORE® septal occluder (GSO) was granted CE mark in Europe in June 2011 for the treatment of

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

atrial septal defectscongenital defectspatent foramen ovaleseptal occluder device
Share on Facebook Share on Twitter Share on Linkedin
Read next article
Impact of changing PSVR thresholds on the patency rates of SFA recanalisation with self-expanding nitinol stents

Latest news

NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Editorial
Treatment of secondary mitral regurgitation in patients with heart failure
Marco Metra et al
July 27, 2021
JAA
This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....
July 20, 2021
Editorial
Coronary flow capacity: where to next?
Nils P. Johnson
July 20, 2021
Ahead of print
Joint EAPCI/ACVC expert consensus document on pVADs
July 20, 2021
NEW
EuroIntervention's new impact factor!
July 1, 2021
STATE OF THE ART
Completeness of Revascularisation in ACS Patients with Multivessel Disease
Valeria Paradies et al.
June 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke